Zachary Roberts, EVP of R&D at Allogene Therapeutics, Inc. (ALLO), sold 18,832 shares at $1.70 ($32K) on 2025-02-03, disclosed to the SEC on 2025-02-05.
Open-market sale of $32k ALLO by EVP of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ALLO | SELL | 2025-01-23 | $48K | — | Filing → |